Bluejay Diagnostics Capital Expenditures (CapEx) Growth & History (BJDX)

Bluejay Diagnostics's capital expenditures (capex) was $173,735 for fiscal 2025.

View full Bluejay Diagnostics company overview

Bluejay Diagnostics annual capital expenditures (capex) history

Bluejay Diagnostics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$173,735−$133,048−43.37%
20242024-12-31$306,783−$397,383−56.43%
20232023-12-31$704,166−$495,104−41.28%
20222022-12-31$1.2M$1.2M+4908.02%
20212021-12-31$23,947

Bluejay Diagnostics capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, Bluejay Diagnostics's capital expenditures (capex) increased from $23,947 to $173,735, a change of $149,788. The latest reported quarter, Q2 2026, shows $142,773.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bluejay Diagnostics source filings ↗

Community posts

It’s quiet here.

No posts about BJDX yet. Start the conversation.

Write the first post